Plaque reduction neutralization assay.

LP Lisa M. Parsons
YA Yanming An
LQ Li Qi
MW Mitchell R. White
RW Roosmarijn van der Woude
KH Kevan L. Hartshorn
JT Jeffery K. Taubenberger
RV Robert P. de Vries
JC John F. Cipollo
request Request a Protocol
ask Ask a question
Favorite

MDCK cells (MDCK.2 [ATCC CRL-2936]) were grown to confluence in 24-well plates. SP-D protein (4 μg/ml) was sequentially diluted 2-fold in d-PBS containing Ca2+ and Mg2+ (up to 0.25 μg/ml), and each dilution was mixed with an equal volume of virus corresponding to 20 to 30 plaques per well. Final SP-D concentrations ranged from 2 μg/ml to 0.125 μg/ml. Following preincubation at room temperature for 45 to 60 min, the mixed samples (100 μl total) were layered onto the MDCK cells. Each sample was tested in triplicate wells. A virus control without SP-D protein was included. After incubation at 37°C for 1 h, a plaque assay with staining after 48 h was performed.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A